---
figid: PMC3174390__ijbsv07p1056g01
figtitle: TGFB/Smads and crosstalk pathways in renal fibrosis and inflammation
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
pmcid: PMC3174390
filename: ijbsv07p1056g01.jpg
figlink: /pmc/articles/PMC3174390/figure/F1/
number: F1
caption: TGF-β/Smads and crosstalk pathways in renal fibrosis and inflammation. After
  binding to TβRII, TGF-β1 activates the TβRI-kinase which phosphorylates Smad2 and
  Smad3. The phosphorylated Smad2 and Smad3 then bind to Smad4 and form the Smad complex,
  which translocates into the nucleus and regulates the target gene transcription,
  including Smad7. Smad7 is an inhibitory Smad that functions to block Smad2/3 activation
  by degrading the TβRI and Smads and to inhibit NF-κB-driven inflammatory response
  by inducing IκBα, an inhibitor of NF-κB. Note that Ang II and AGEs can activate
  Smads independent of TGF-β1 via the ERK/p38/MAPK crosstalk pathway. Blue lines (symbols)
  indicate protective or negative regulation pathways, while red arrows (symbols)
  represent pathogenic or positive regulation pathways.
papertitle: Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation.
reftext: Hui Yao Lan. Int J Biol Sci. 2011;7(7):1056-1067.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9685052
figid_alias: PMC3174390__F1
figtype: Figure
redirect_from: /figures/PMC3174390__F1
ndex: 285783a6-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3174390__ijbsv07p1056g01.html
  '@type': Dataset
  description: TGF-β/Smads and crosstalk pathways in renal fibrosis and inflammation.
    After binding to TβRII, TGF-β1 activates the TβRI-kinase which phosphorylates
    Smad2 and Smad3. The phosphorylated Smad2 and Smad3 then bind to Smad4 and form
    the Smad complex, which translocates into the nucleus and regulates the target
    gene transcription, including Smad7. Smad7 is an inhibitory Smad that functions
    to block Smad2/3 activation by degrading the TβRI and Smads and to inhibit NF-κB-driven
    inflammatory response by inducing IκBα, an inhibitor of NF-κB. Note that Ang II
    and AGEs can activate Smads independent of TGF-β1 via the ERK/p38/MAPK crosstalk
    pathway. Blue lines (symbols) indicate protective or negative regulation pathways,
    while red arrows (symbols) represent pathogenic or positive regulation pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tgfb1
  - Agt
  - Tnf
  - Il1b
  - Tgfbr1
  - Agtr1a
  - Agtr1b
  - Ager
  - Mok
  - Syt1
  - Mapk14
  - Smad7
  - Smad2
  - Smad3
  - Ephb1
  - Smad4
  - TGFB1
  - ANGPT2
  - VPS51
  - TNF
  - IL1B
  - TGFBR1
  - AGTR1
  - ATM
  - SLC33A1
  - PGR-AS1
  - AGTR2
  - AGER
  - MOK
  - TGFBR2
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKBIA
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - SMAD7
  - SMAD2
  - SMAD3
  - EPHB2
  - MAPK3
  - SMAD4
  - Serpinb9d
  - Tgfbr2
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Ephb2
  - Mapk1
---
